Assembly Biosciences Inc (ASMB)
13.36
+0.31
(+2.38%)
USD |
NASDAQ |
Apr 24, 12:57
Assembly Biosciences Free Cash Flow (Quarterly): 73.58M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.58M |
| September 30, 2023 | -13.98M |
| June 30, 2023 | -13.68M |
| March 31, 2023 | -23.43M |
| December 31, 2022 | -19.25M |
| September 30, 2022 | -19.92M |
| June 30, 2022 | -17.88M |
| March 31, 2022 | -27.50M |
| December 31, 2021 | -19.38M |
| September 30, 2021 | -18.88M |
| June 30, 2021 | -21.81M |
| March 31, 2021 | -36.42M |
| December 31, 2020 | -27.02M |
| September 30, 2020 | 10.65M |
| June 30, 2020 | -23.52M |
| March 31, 2020 | -25.28M |
| December 31, 2019 | -20.54M |
| September 30, 2019 | -18.60M |
| June 30, 2019 | -21.06M |
| March 31, 2019 | -25.43M |
| December 31, 2018 | -16.94M |
| September 30, 2018 | -16.72M |
| June 30, 2018 | -16.10M |
| March 31, 2018 | -15.54M |
| December 31, 2017 | -10.13M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.46M |
| June 30, 2017 | -12.36M |
| March 31, 2017 | 34.94M |
| December 31, 2016 | -11.15M |
| September 30, 2016 | -7.897M |
| June 30, 2016 | -6.768M |
| March 31, 2016 | -9.213M |
| December 31, 2015 | -5.466M |
| September 30, 2015 | -5.186M |
| June 30, 2015 | -4.400M |
| March 31, 2015 | -3.704M |
| December 31, 2014 | -3.722M |
| September 30, 2014 | -3.893M |
| June 30, 2014 | -2.320M |
| March 31, 2014 | -5.188M |
| December 31, 2013 | -5.394M |
| September 30, 2013 | -4.655M |
| June 30, 2013 | -3.384M |
| March 31, 2013 | -4.370M |
| December 31, 2012 | -3.071M |
| September 30, 2012 | -5.284M |
| June 30, 2012 | -6.939M |
| March 31, 2012 | -6.090M |
| December 31, 2011 | -16.33M |
| September 30, 2011 | -4.069M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.42M
Minimum
Mar 2021
73.58M
Maximum
Dec 2023
-14.94M
Average
-19.92M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Petros Pharmaceuticals Inc | -2.260M |
| Spectral AI Inc | -5.338M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |